RhumbLine Advisers’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $44.5K | Buy |
|
|||||
|
2024
Q4 | $131K | Buy |
|
|||||
|
2024
Q3 | $119K | Sell |
|
|||||
|
2024
Q2 | $109K | Buy |
|
|||||
|
2024
Q1 | $227K | Buy |
|
|||||
|
2023
Q4 | $135K | Hold |
|
|||||
|
2023
Q3 | $175K | Buy |
|
|||||
|
2023
Q2 | $299K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $178K | Sell |
|
|||||
|
2020
Q4 | $138K | Buy |
|
|||||
|
2020
Q3 | $122K | Sell |
|
|||||
|
2020
Q2 | $182K | Buy |
|